Hanmi Science Co., Ltd.
Price Chart
Key facts
- Market Cap
- ₩2.95T
- P/E
- 24.7x
- P/B
- 3.03x
- ROE
- 13.1%
Hanmi Science Co., Ltd.
Hanmi Science Co., Ltd. is a prominent South Korean company engaged in the pharmaceutical and biotechnology sectors, with a focus on developing innovative healthcare solutions. As the holding company of Hanmi Pharmaceuticals, its primary function is to drive drug discovery and ensure the availability of effective medical products. Hanmi Science undertakes research and development activities, emphasizing biopharmaceuticals and chemical drugs, particularly in areas like oncology, diabetes, and autoimmune diseases. The company plays a vital role in the healthcare industry by advancing medical research and contributing to improving public health outcomes. Operating as a key player within the biotechnology market, Hanmi Science influences the proliferation of cutting-edge therapies and medicines, both in South Korea and internationally. Its commitment to innovation and therapeutic advancements has positioned it as a critical contributor to the global pharmaceuticals landscape, impacting not only direct healthcare provision but also broader industry research collaborations and partnerships.
- CEO
- 김재교
- Employees
- 443
- Website
- hanmiscience.co.kr